(İstanbul Üniversitesi)
(İstanbul Üniversitesi)
(İstanbul Üniversitesi)
Selmin KÖSE
(İstanbul Bilim Üniversitesi)
(İstanbul Üniversitesi)
(İstanbul Üniversitesi)
(İstanbul Üniversitesi)
Yıl: 2019Cilt: 54Sayı: 4ISSN: 1306-0015 / 1308-6278Sayfa Aralığı: 256 - 263İngilizce

100 0
The relationship between cardiometabolic risks and vitamin D levels with the degree of obesity
Aim: The aim of this study was to evaluate the cardiometabolic risk factors including vitamin D levels according to the degree of obesity in adolescents. Material and Methods: This is a retrospective cross-sectional study. A total of 363 overweight/obese adolescents aged between 11 and 18 years who were evaluated in our clinic from January 2012 to December 2015 were included in the study. The degree of obesity was calculated as the body mass index standard deviation. Hypertension, dyslipidemia, hyperinsulinemia, hyperglycemia, insulin resistance, and vitamin D deficiency were defined as cardiometabolic risk factors. Mann-Whitney U, Chi-square, Spearman and Pearson’s correlation tests, and linear regressions analyses were used for statistical analyses. Results: Of the 319 (n=319/363) adolescents, all of whose cardiometabolic risk factors were known, 267 (85.7%) had at least one cardiometabolic risk factor. The body mass index standard deviation had a positive correlation with the number of cardiometabolic risk factors (p<0.001). In the linear regression models in which sex and age were considered as covariates, an increase of one unit in the body mass index standard deviation led to an increase of 6.085 mm Hg in systolic blood pressure, 4.4 mm Hg in diastolic blood pressure, 1.59 points in HOMA-IR, 13% in insulin level, and a decrease of 2.16 ng/mL in vitamin D levels. Conclusion: In adolescents, the number of cardiometabolic risk factors increases as the degree of obesity increases. The determination of the severity of obesity can help to identify individuals at greater risk for higher blood pressure, impaired glucose metabolism, and lower serum vitamin D levels. On the other hand, the degree of obesity may not reflect the presence of abnormal lipid and glucose levels.
Fen > Tıp > Pediatri
DergiAraştırma MakalesiErişime Açık
  • 1. WHO. Obesity and overweight, cited February 2018. Available from: Accsessed, August 15, 2018.
  • 2. de Onis M, Martínez-Costa C, Núñez F, et al. Association between WHO cut-offs for childhood overweight and obesity and cardiometabolic risk. Public Health Nutr 2013;16: 625−30. [CrossRef]
  • 3. Reinehr T, Andler W, Denzer C, Siegried W, Mayer H, Wabitsch M. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis 2005; 15: 181−7. [CrossRef]
  • 4. Morais PR, Sousa AL, Jardim Tde S, et al. Correlation of Insulin resistance with Anthropometric Measures and Blood Pressure in Adolescents. [Article in English, Por tuguese]. Arq Bras Cardiol 2016; 106: 319−26. [CrossRef]
  • 5. Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic Risks and Severity of Obesity in Children and Young Adults. N Engl J Med 2015; 373: 1307−17.
  • 6. Makkes S, Renders CM, Bosmans JE, van der BaanSlootweg OH, Seidell JC. Cardiometabolic risk factors and quality of life in severely obese children and adolescents in The Netherlands. BMC Pediatr 2013; 13: 62−71.
  • 7. Mandarino NR, Júnior Fd, Salgado JV, Lages JS, Filho NS. Is vitamin d deficiency a new risk factor for cardiovascular disease? Open Cardiovasc Med J 2015; 9: 40−9. [CrossRef]
  • 8. Peterson CA, Tosh AK, Belenchia AM. Vitamin D insufficiency and insulin resistance in obese adolescents. Ther Adv Endocrinol Metab 2014; 5: 166−89. [CrossRef]
  • 9. Pacifico L, Anania C, Osborn JF, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011; 165: 603−11. [CrossRef]
  • 10. Wakayo T, Whiting SJ, Belachew T. Vitamin D Deficiency is Associated with Overweight and/or Obesity among Schoolchildren in Central Ethiopia: A Cross-Sectional Study. Nutrients 2016; 8: 190−202. [CrossRef]
  • 11. Field AE, Cook NR, Gillman MW. Weight status in childhood as a predictor of becoming overweight or hypertensive in early adulthood. Obes Res 2005; 13: 163−9.
  • 12. Guo SS, Wu W, Chumlea WC, Roche AF. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr 2002; 76: 653−8. [CrossRef]
  • 13. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010; 362: 485−93. [CrossRef]
  • 14. Inge TH, King WC, Jenkins TM, et al. The effect of obesity in adolescence on adult health status. Pediatrics 2013; 132: 1098−104. [CrossRef]
  • 15. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240−3.
  • 16. Neyzi O, Bundak R, Gökçay G, et al. Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children. J Clin Res Pediatr Endocrinol 2015; 7: 280−93. [CrossRef]
  • 17. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and sdolescents: Summary report. Pediatrics 2011; 128: 213−56. [CrossRef]
  • 18. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115: 500−3. [CrossRef]
  • 19. Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010; 2: 100−6. [CrossRef]
  • 20. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Subcommittee On Screening And Management Of High Blood Pressure In Children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140: e20171904.
  • 21. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911−30.
  • 22. FAQ How Do I Interpret A Regression Model When Some Variables Are Log Transformed? Available from: faqhow-do-i-interpret-a-regression-model-when-somevariables-are-log-transformed/. Accessed, July 27, 2017.
  • 23. Rizzo AC, Goldberg TB, Silva CC, Kurokawa CS, Nunes HR, Corrente JE. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents. Nutr J 2013; 12; 12−9. [CrossRef]
  • 24. Jiang SZ, Lu W, Zong XF, Ruan HY, Liu Y. Obesity and hypertension. Exp Ther Med 2016; 12: 2395−9. [CrossRef]
  • 25. Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity-induced hypertension. Hyper tens Res 2010; 33: 386−93. [CrossRef]
  • 26. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23: 1170−8. [CrossRef]
  • 27. Marquina C, Mousa A, Scragg R, de Courten B. Vitamin D and cardiometabolic disorders: a review of current evidence, genetic determinants and pathomechanisms. Obes Rev 2019; 20: 262−77. [CrossRef]
  • 28. Vanlint S. Vitamin D and Obesity. Nutrients 2013; 5: 949−56. [CrossRef]
  • 29. Zakharova I, Klimov L, Kuryaninova V, et al. Vitamin D Insufficiency in Overweight and Obese Children and Adolescents. Front Endocrinol (Lausanne) 2019; 10: 103.
  • 30. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690−3. [CrossRef]
  • 31. Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 2007; 103: 679−81. [CrossRef]
  • 32. Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517−24. [CrossRef]
  • 33. Queiroz DJM, Silva AS, Diniz ADS, et al. Vitamin D insufficiency/deficiency and its association with cardiometabolic risk factors in Brazilian adolescents. Nutr Hosp 2019; 36: 142−8.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.